EDGAR Filing Documents for 0001104659-21-074998

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0001104659-21-074998

Filing Date

2021-06-01

Accepted

2021-06-01 16:02:10

Documents

Group Members

D. E. SHAW & CO., L.L.C.D. E. SHAW VALENCE PORTFOLIOS, L.L.C.DAVID E. SHAW

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G/A	tm2118098d2_sc13ga.htm	SC 13G/A	68987
2	EXHIBIT 1	tm2118098d2_ex1.htm	EX-99.1	5745
3	EXHIBIT 2	tm2118098d2_ex2.htm	EX-99.2	5790
4	EXHIBIT 3	tm2118098d2_ex3.htm	EX-99.3	5953
	Complete submission text file	0001104659-21-074998.txt		88494

Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036

Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000

D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301

Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952

Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)